{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:30Z","timestamp":1707524730598},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,4]]},"DOI":"10.7759\/cureus.28771","type":"journal-article","created":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T16:16:30Z","timestamp":1662308190000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Dystonia With Rhabdomyolysis Induced by Paliperidone Palmitate: A Rare Adverse Effect"],"prefix":"10.7759","author":[{"given":"Nishant","family":"Allena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sai","family":"Doppalapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Tank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabih","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Extrapyramidal side effects: a historical perspective","volume":"48","author":"Rifkin A","year":"1987","unstructured":"Rifkin A. Extrapyramidal side effects: a historical perspective. J Clin Psychiatry. 1987, 48:3-6.","journal-title":"J Clin Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S49944","article-title":"Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies","volume":"9","author":"Gopal S","year":"2013","unstructured":"Gopal S, Liu Y, Alphs L, Savitz A, Nuamah I, Hough D. Incidence and time course of extrapyramidal symptoms with oral and long-acting injectable paliperidone: a posthoc pooled analysis of seven randomized controlled studies. Neuropsychiatr Dis Treat. 2013, 9:1381-92. 10.2147\/NDT.S49944","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s43045-021-00097-6","article-title":"Management of constipation in patients with schizophrenia\u2014a case study and review of literature","volume":"28","author":"Sarangi A","year":"2021","unstructured":"Sarangi A, Armin S, Vargas A, Chu VN, Fain K, Nelson J. Management of constipation in patients with schizophrenia\u2014a case study and review of literature. Middle East Curr Psychiatry. 2021, 28:17. 10.1186\/s43045-021-00097-6","journal-title":"Middle East Curr Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20567","article-title":"Management of common adverse effects of antipsychotic medications","volume":"17","author":"Stroup TS","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018, 17:341-56. 10.1002\/wps.20567","journal-title":"World Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2019.08.007","article-title":"Functional movement disorders","volume":"176","author":"Galli S","year":"2020","unstructured":"Galli S, B\u00e9reau M, Magnin E, Moulin T, Aybek S. Functional movement disorders. Rev Neurol (Paris). 2020, 176:244-51. 10.1016\/j.neurol.2019.08.007","journal-title":"Rev Neurol (Paris)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-801772-2.00005-9","article-title":"Epidemiology","volume":"139","author":"Carson A","year":"2016","unstructured":"Carson A, Lehn A. Epidemiology. Handb Clin Neurol. 2016, 139:47-60. 10.1016\/B978-0-12-801772-2.00005-9","journal-title":"Handb Clin Neurol"},{"key":"ref7","article-title":"Dystonic reactions","author":"Lewis K","year":"2022","unstructured":"Lewis K, O'Day CS. Dystonic reactions. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/656370","article-title":"Second-generation antipsychotics and extrapyramidal adverse effects","volume":"2014","author":"Divac N","year":"2014","unstructured":"Divac N, Prostran M, Jakovcevski I, Cerovac N. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014, 2014:656370. 10.1155\/2014\/656370","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.23.3.jnpe51","article-title":"Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia","volume":"23","author":"Wu YF","year":"2011","unstructured":"Wu YF, Chang KY. Aripiprazole-associated rhabdomyolysis in a patient with schizophrenia. J Neuropsychiatry Clin Neurosci. 2011, 23:E51. 10.1176\/jnp.23.3.jnpe51","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-015-0092-x","article-title":"Comparative pharmacology of risperidone and paliperidone","volume":"15","author":"Corena-McLeod M","year":"2015","unstructured":"Corena-McLeod M. Comparative pharmacology of risperidone and paliperidone. Drugs R D. 2015, 15:163-74. 10.1007\/s40268-015-0092-x","journal-title":"Drugs R D"},{"key":"ref11","article-title":"Paliperidone-induced rhabdomyolysis: a case report","volume":"43","author":"Fern\u00e1ndez-Macho JG","year":"2015","unstructured":"Fern\u00e1ndez-Macho JG, Esp\u00e1rrago-Llorca G, Morales-G\u00f3mez GR, Guisado-Mac\u00edas JA. Paliperidone-induced rhabdomyolysis: a case report. Actas Esp Psiquiatr. 2015, 43:66-8.","journal-title":"Actas Esp Psiquiatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40211-020-00377-3","article-title":"Rhabdomyolysis induced by paliperidone palmitate (Article in German)","volume":"35","author":"Klein B","year":"2021","unstructured":"Klein B, Silberbauer C. Rhabdomyolysis induced by paliperidone palmitate (Article in German). Neuropsychiatr. 2021, 35:98-101. 10.1007\/s40211-020-00377-3","journal-title":"Neuropsychiatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2020.01.011","article-title":"Treatment of functional movement disorders","volume":"38","author":"LaFaver K","year":"2020","unstructured":"LaFaver K. Treatment of functional movement disorders. Neurol Clin. 2020, 38:469-80. 10.1016\/j.ncl.2020.01.011","journal-title":"Neurol Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.tv17016ah4c","article-title":"Epidemiology, prevention, and assessment of tardive dyskinesia and advances in treatment","volume":"78","author":"Correll CU","year":"2017","unstructured":"Correll CU, Kane JM, Citrome LL. Epidemiology, prevention, and assessment of tardive dyskinesia and advances in treatment. J Clin Psychiatry. 2017, 78:1136-47. 10.4088\/JCP.tv17016ah4c","journal-title":"J Clin Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/102410-acute-dystonia-with-rhabdomyolysis-induced-by-paliperidone-palmitate-a-rare-adverse-effect","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:45Z","timestamp":1707507585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/102410-acute-dystonia-with-rhabdomyolysis-induced-by-paliperidone-palmitate-a-rare-adverse-effect"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,4]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.28771","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,4]]}}}